Thanks Telepanel.
Your link had errors in it. Here is the correct link.
https://www.abstractsonline.com/pp8/#!/9045/presentation/1852
Looks like pre-clinical work in ER+ breast cancer cells with ZEN-3694 in combo with CDK 4/6 inhibition. It is not related to the triple negative breast cancer clinical trial with Pfizer using PARP inhibitors and ZEN-3694.
It is also accessible from the Zenith home page. Scroll to the bottom of the home page where they announce participating in virtual AACR and click read more. Right now it is only on home page and not on events page.
BDAZ